Federated Hermes, Inc. 13D and 13G filings for Rhythm Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-09-07 10:14 am Sale | 2023-08-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | FEDERATED HERMES INC. FHI | 2,341,335 4.110% | -3,963,147 (-62.86%) | Filing |
| 2023-02-01 11:57 am Purchase | 2022-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | FEDERATED HERMES INC. FHI | 6,304,482 11.190% | 1,239,369 (+24.47%) | Filing |
| 2022-04-11 11:14 am Purchase | 2022-03-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | FEDERATED HERMES INC. FHI | 5,065,113 10.060% | 2,261,778 (+80.68%) | Filing |
| 2022-02-14 2:53 pm Purchase | 2021-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | FEDERATED HERMES INC. FHI | 2,803,335 5.580% | 1,027,631 (+57.87%) | Filing |
| 2021-12-10 1:18 pm Sale | 2021-11-30 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | FEDERATED HERMES INC. FHI | 1,775,704 3.530% | -841,896 (-32.16%) | Filing |
| 2021-02-12 3:20 pm Purchase | 2020-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | FEDERATED HERMES INC. FHI | 2,617,600 5.920% | 2,617,600 (New Position) | Filing |